RA Shortens Life Expectancy of Patients with RA & Increases Healthcare Costs
Global Prevalence & Burden of Musculoskeletal Disorders
Race Matters in COVID-19 Outcomes for Patients with Rheumatic Disease
A High HAQ at Baseline in Early RA Is a Bad Sign
The Glass Ceiling in Academic Rheumatology
Pulmonary Adverse Events with Low-Dose Methotrexate
Ticagrelor Lowers the Risk for OA Compared with Clopidogrel
Nerve Growth Factor Inhibitor Study Highlights Promise as an OA Pain Treatment
RA Patients Taking Either 15 mg or 30 mg Dose of Upadacitinib Experience Improvement
- 1
- 2
- 3
- …
- 9
- Next Page »